• Article highlight
  • Article tables
  • Article images

Article History

Received : 13-01-2023

Accepted : 05-04-2023



Article Metrics




Downlaod Files

   


Article Access statistics

Viewed: 489

PDF Downloaded: 523


Get Permission Singh, Kumar, Nirala, and Bhadauria: Hepatoprotective potential of propolis


Introduction

From the ancient time, peoples are enjoying charmed of propolis. The Arabians, Egyptians, and Roman physicians have documented propolis for its various medicinal properties and they have used it for mummifying, protection from wound, as a mouthwash, and several other activities. Moreover, propolis was widely famous for its remedial effects. Healing properties of propolis is mentioned as the “Balm of Gilead” in Holy Bible.1 Famous Greek philosopher, Aristotle mentioned propolis in his book “Historia Animalium” a substance, that honey bees smeared at their hive entry as a cure for bruises and sores.2 Roman scholar, Plinius (23–79 A.D.) hypothesized that propolis originates in the buds of trees like willow, poplar, elm, and reed. He also mentioned about use of propolis at that time “current physicians use propolis as a medicine because it’s extracts reduces swelling, softens indurations and relieves pain”.3

Propolis has been widely used to cure several hepatic disorders, including “acute liver failure, alcoholic and non-alcoholic fatty liver diseases, liver fibrosis, liver cirrhosis and liver cancer”. In this review a portrait has been made on propolis as a potent hepatoprotective agent to cure liver from acute liver failure to hepatocellular carcinoma.

Propolis and its Properties

Propolis is a waxy substance collected by bees from different plant exudates. Plants protects themselves from foreign pathogens by producing several phytochemicals such as phytoalexins, saponins, polyphenols, esters, alcohols, many of which have been extracted and are used in treatment of several diseases and are very good source of antioxidants, vitamins, and several plants based secondary metabolites.1 Plant defence compounds, collected by bees mainly include phenols and terpenoids. Honey bees and other species of social bees identify these properties of plants, collect, and use these plant products to make propolis and further used to protect the colony from virus, bacteria, protozoans, and several other enemies.4 Bees in colonies that collects propolis are healthier and live longer, comparison to other worker bees that do not collect propolis, and consumption of propolis by bees supplements their immune system to protect them from several pathological challenges.5

The compounds present in propolis varies as per the flora of that place from where it is collected, season of collection (as number of plants that flower and their composition of phytochemicals varies according to the season, stress and photoperiodism) as this variability affects the medicinal properties of compounds produced by plants. Standardized propolis products does not vary in their main bioactive composition and is usually regarded as safe, with minimal interaction with pharmaceutical drugs, which is also proven in clinical trials.6 In current research scenario, propolis has been reported to possesses antioxidant, antibacterial, antiviral, anti-inflammatory,7 immunomodulatory, hepatoprotective, nephroprotective,8, 9 cardioprotective, antidiabetic and anticancer activity.10 Historically propolis has been widely used to cure several diseases. Propolis has also been considered over other natural alternatives products because it is generally less expensive, easily available, and rarely causes any side effects and as it is collected from different sources, so it contains various natural products from various medicinal plants.11, 12

Hepatoprotective Activity of Propolis

Liver diseases are a set of pathological conditions which are characterised by the several liver function test markers, normally a healthy adult liver consists of 5 or less than 5% fat content, if this fat content increases in hepatocytes, the person suffers from fatty liver disease or steatosis.13 If this condition is not treated and further symptoms develops, which shows ballooning of hepatocytes and inflammation in liver cells, however, this condition is also treatable and if not treated these symptoms further develops in to fibrosis14 which are having three different stages and condition can be reversed but at this point if disease is not treated, condition now develops into cirrhosis which is having no any medicine for treatment, although their few medicines are available which can slowed down the process of cirrhosis but cannot treat completely and the person suffering from this condition have to go for liver transplantation otherwise hepatocellular carcinoma will develop and soon person may die.15

Propolis and Acute Liver Failure

Acute liver failure is most common clinical manifestation related with liver injury, in which level of liver function test marker enzymes (AST, ALT, ALP, GGT, bilirubin total and bilirubin direct) significantly elevated and causes problem in normal functioning of liver.16 Propolis is a very good hepatoprotective agent against acute liver failure condition. Propolis increases the tissue glutathione level while stop lipid peroxidation level. Consequently, propolis has been reported to increase antioxidant activity against mercury induced-toxicity by regulating antioxidant enzyme system.17 Studies also showed that propolis have protective role against CCl4 induced hepatorenal oxidative stress and resultant injury.18 Propolis showed hepato-protective activity in liver damage of rats caused by alcohol, CCl4 and acetaminophen. Banskota et al.19 isolated several phenolic compounds and diterpenic acids from propolis showing hepatoprotective activity. Bhadauria et al.,20 have reported multiple treatment of propolis can prevent the level of liver function test marker enzymes towards control if propolis is taken regularly, it can save liver from model hepatotoxicant 21 several other papers have found that propolis prevents liver injury from toxic elements such as aluminium,22 acetaminophen,23, 24 mercury,25 and beryllium.26

Role of Propolis in Drug Induced Toxicity

People suffer with diseases, they take some type of medicines, which are alien to their body. Body assumes these substances as alien and these aliens produce some type of toxicity inside the body either given acutely or chronically.27 Cancer and tuberculosis are the two most common disease, which uses wide range of medicines. Consuming theses medicines causes several side effects along with toxicity in liver and kidney as they are major organs responsible for the metabolism of these medicines and their reactive metabolites.28 Cancer is the most prominent health complications of current scenario, ranked as second most common disease in the world, followed by cardiac diseases in several countries in the world.29 Cancer treatment includes chemotherapy, radiotherapy, surgery, and now immunotherapy. These methods are used in the treatment according to type of cancer and level of severity. Chemotherapy is a method, which is having toxic effects also, especially against multiplying cells, and is performed with natural or synthetic chemicals. The main aim of chemotherapy is to increase patients’ life hope and provide further a better life. However, several chemotherapy-related complications and toxic effects are reported depending on the medication used. 30 The common non-hazardous and natural compounds such as propolis is used from the ancient times to cure hepatic abnormalities and is very rich source of antioxidant molecule that protects liver from several xenobiotics. Propolis is one of the natural compounds that is having a very good source of antioxidant and restores cellular functions by preventing several side effects caused by alien substances to our body. Seven et al., 31 reported propolis and its nano-formulation against cisplatin induced toxicological manifestations in rats and in their study, they concluded that propolis and its nanoparticles protects liver and kidney by modulating Bcl-2 and Bax levels. Along with chemotherapeutic drugs, antituberculosis drugs also causes several toxic effects in liver and kidney. 32 Treatment of tuberculosis takes six-month course of medicines, including rifampicin, isoniazid, ethambutol, and pyrazinamide, which exerts great side effects on liver and kidney. Sahu et al., 33 reported protective effects of propolis against antituberculosis drugs (ATDs) resulted hepato-renal toxicities. Administration of ATDs for 8 weeks along with propolis at (100, 200, 400 mg/kg) conjointly in rats and found that increase in aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, triglyceride, and cholesterol along with reduction in glucose and albumin level were noted after ATDs induced hepatic injury and recovery was observed in propolis groups, maximum recovery was noted in 400 mg/kg group. Increase in oxidative stress triglyceride, cholesterol and CYP2E1 activity and decrease in antioxidant pool (reduced glutathione, catalase, superoxide dismutase, glutathione reductase, glutathione peroxidase, glucose-6-phosphatase dehydrogenase) were observed. Histopathological and electron microscopic observations also revealed their biochemical results indicated hepato-nephro protective potential of propolis whereas, TNF-α, IL-6 and IGF-1 also confirmed therapeutic role of propolis at molecular level in their study. In the conclusion, propolis prevents drug induced toxicity by combating the free radicals and maintaining the level of antioxidant enzymes by preventing free radicals’ activity, maintaining the level of CYP2E1 activity, maintaining inflammatory markers level, also confirmed by light microscopy study of tissues and electron microscopy study.

Propolis and Fatty Liver Diseases

The term fatty liver diseases (NAFLD) or steatosis describes long-lasting liver abnormalities, characterized by excess accumulation of lipid droplets (steatosis) without excess alcohol intake. Irregular accumulation of fat if becomes >5% in hepatocytes, deprived of any evidence of hepatic injury or hepatic fibrosis is generally termed as simple or bland hepatic steatosis. 34 However, a good number of patients with steatosis develops to an advanced form of the disease termed as Non-alcoholic steatohepatitis (NASH). In NASH, steatosis exists with hepatic injury and inflammation and may trigger further necrosis, fibrosis, and cirrhosis, in addition to develop a risk of liver cancer. 35 The NAFLD is usually more commonly found in persons with central obesity (deposited abdominal fat excessively), type 2 diabetes, hypertension, and dyslipidaemia. 36 Till date, no pharmacological compound has been licensed specifically for the treatment of NAFLD. The recommended medication for NAFLD is mainly focuses on lifestyle changes including proper diet and physical activities. Although biological machineries, which leads the progression of NAFLD has not been completely clarified, but oxidative stress is suggested as a key factor in the development of NASH from NAFLD. 37 As per Kismet et al., 38 propolis on NAFLD showed protection observed by histopathological, biochemical, and anti-inflammations activities. From their study they confirm that the anti-oxidant and anti-inflammatory properties of propolis prevents the progression of NAFLD to NASH and conclude that further randomised clinical study is needed which can confirms role of propolis in the treatment of NASH and NAFLD.

Propolis and Hepatitis

Hepatitis of liver refers as an inflammatory state of liver, which is usually caused by viral infections, but several other possible causes of hepatitis are also reported. These comprise mainly autoimmune hepatitis and hepatitis occurs due to secondary result of medications, drugs, toxins, alcohol, or any xenobiotics induction.39 Autoimmune hepatitis occurs when our own body cells produce antibodies against our own liver tissues. Excessive consumption of alcohol may results into liver cell damage and inflammation, which is termed as alcoholic hepatitis condition.40 Alcohol directly injures hepatic cells. With the time progression, it causes permanently damage to hepatic cells and may lead to failure of liver and liver cirrhosis, a thickening and scarring in the hepatic tissues. Apart from alcohol other causes of hepatitis are overdose of medications and exposure to xenobiotics such as acetaminophen, carbon tetra chloride, lipopolysaccharide etc. Hassan et al.,41 have tested Saudi propolis against CCl4 induced acute hepatitis and found in their experiment that propolis contains several compounds from gas chromatographic separation results revealed that propolis have forty-one natural compounds. In his result of hepatitis, they found that propolis is a compound that inhibits the elevation of liver function test markers enzymes, level of Malondialdehyde (MDA) which indicates the level of oxidative stress in liver tissues, he also found that propolis restores level of enzymatic activity of Glutathione-S-transferase (GST), Catalase (CAT), superoxide dismutase (SOD) and glutathione peroxidase (GSH) in liver against hepatitis. Mounieb et al., 42 reported that the propolis treatment against concanavalin A induced hepatitis have shown better protection in oxidative stress (in terms of lipid peroxidation), antioxidant enzymes (such as SOD, CAT etc.) and regulating the level of cytokines (mainly TGF-β, TNF-α, and IL-6) in hepatitis rats and have resulted in improved level of liver function test markers (AST, ALT, ALP, GGT, Bilirubin). Results of El-Mahalaway et al.,43 also corelates several other findings related with hepatoprotective activity of propolis as in their experiment they reported lipopolysaccharide and D-galactosamine induced hepatitis and have noted vacuoles necrosis in hepatic cells and damaged hepatocytes histologically as well as immunobiologically in toxicant group but treatment with propolis preserved this cellular structure with its antioxidant activity.

Propolis and Liver Fibrosis

During liver fibrosis, excess accumulation of extracellular matrix proteins occurs mainly collagen. Liver fibrosis further develops into cirrhosis, ultimately liver failure which requires liver transplantation. 44 Till date our information towards mechanisms of liver fibrosis has become greatly advanced. Activated stellate cells, portal fibroblasts have been recognized as main collagen-producing cells in the damaged liver. Activation of these cells produces fibrogenic cytokines mainly TGF-β1, leptin and angiotensin-II. Reversibility of hepatic fibrosis in patients have recently been documented in some experiments, which have shown researchers to invent novel antifibrotic drugs.45 Although several therapeutic interferences have been reported to be effective in experimental models of liver fibrosis but their efficacy in humans is still not well documented.Liver fibrosis is the excessive accumulation of extracellular matrix proteins including collagen that occurs in most types of chronic liver diseases. Advanced liver fibrosis results in cirrhosis, liver failure, and portal hypertension and often requires liver transplantation. Our knowledge of the cellular and molecular mechanisms of liver fibrosis has greatly advanced. Activated hepatic stellate cells, portal fibroblasts, and myofibroblasts of bone marrow origin have been identified as major collagen-producing cells in the injured liver. These cells are activated by fibrogenic cytokines such as TGF-β1, angiotensin II, and leptin. Reversibility of advanced liver fibrosis in patients has been recently documented, which has stimulated researchers to develop antifibrotic drugs. Emerging antifibrotic therapies are aimed at inhibiting the accumulation of fibrogenic cells and/or preventing the deposition of extracellular matrix proteins. Although many therapeutic interventions are effective in experimental models of liver fibrosis, their efficacy and safety in humans is unknown. This review summarizes recent progress in the study of the pathogenesis and diagnosis of liver fibrosis and discusses current antifibrotic strategies.

Liver fibrosis was earlier believed to be an irreparable machinery due to collapse of hepatic parenchyma and their substitution with the excess collagen tissue but now it is model for wound-healing comeback to chronic liver injuries. However, it got major consideration from 1980s, when hepatic stellate cells (HSCs), recognized as the chief collagen-producing cells.46 Models for studying mechanism of fibrogenesis in rats and in transgenic mice have been already developed by using several chemicals such as thioacetamide, carbon tetrachloride and so on. Since the demonstration of the reports that even advanced hepatic fibrosis is rescindable, researchers are in continuous discovering antifibrotic therapies with natural origin and without any side effect such as propolis. 47 Inflammation is responsible for the pathogenesis of steatosis and fibrosis.48 A study performed by Zhao et al.49 18 weeks intervention of propolis at 900 mg/kg daily dose significantly reduced TNF-α concentrations, which is a major inflammatory cytokine. A clinical trial disclosed propolis supplementation recovers hepatic steatosis and fibrosis score in patients having NAFLD, 50 involving total of 54 patients with NAFLD and have found that propolis improves liver function test markers, blood glucose level fasting as well as after meal and reduces the level of highly sensitive C-reactive proteins (hsCRP) at 250 mg/kg dose twice in a day for four months. In recent years, Kismet et al. 39 found that propolis intake ameliorates histological score during steatosis, hepatocellular ballooning, and lobular inflammation, which reduces liver function test markers enzymes in rats with non-alcoholic steatohepatitis and hepatic fibrosis additionally, histopathology of liver.51 Inflammation, oxidative stress also plays a key role in the development of fibrosis through activation of stellate cells.52 Bhadauria, 20 have reported defensive part of propolis against carbon tetrachloride (CCl4) induced hepatic fibrosis, in her experiment she has given propolis two weeks at 200mg/kg after induction of fibrosis by CCl4 treatment of five weeks and reported that treatment with propolis significantly reverses level of transaminases, antioxidant enzymes and oxidative stress level towards control which was also confirmed by histopathological observations. Galangin, a polyphenol present in propolis suppresses inflammation and oxidative stress through activation of nuclear factor erythroid 2 (Nrf-2).53 Studies have shown that galangin reduces steatosis by promoting autophagy in hepatocytes 54 and prevents HSCs proliferation and collagen gene appearance by constraining TGF-β expression also. A phenolic compound obtained in propolis named caffeic acid phenethyl ester (CAPE), overwhelms translocation of NF-κβ through IκB degradation or blocking the bindings of NF-κB to genetic materials. Pinocembrin (one more flavonoid present in propolis) has downregulated the appearance of TNF-α, IL-1β, and IL-6 genes. The molecular pathway of the pinocembrin explained that pinocembrin inhibits IκBα, JNK, ERK1/2, and p38MAPK phosphorylation results into inflammatory paths blockage. 55 Other than its anti-inflammatory action pinocembrin also inhibits fibrogenesis by Nrf-2 pathway and halting NF-κβ and TGF-β1 signalling mechanism. 56 The medical trials are restricted due to the lack of liver biopsy examination as ethical considerations are not easy. Izzularab et al., 57 have reported propolis nanoparticles are also having tremendous property to minimise side effects of hepatic fibrosis and nephropathy induced by carbon tetrachloride, in their experiment they found that along with oxidative stress and antioxidant enzymes gene level regulation of TGF-β, nephrin, and Caspase-9 increases drastically, while decrease in Bcl-2 level was reported, treatment of propolis nanoparticles at dose of 200 mg/kg reduces expression of these enzymes towards normal group.

Propolis and Cirrhosis

Hepatic cirrhosis is explained as the “progression of regenerative nodules which are surrounded by fibrous bands in response to chronic liver injuries, which leads to portal hypertension and end stage liver diseases”. 10 Current developments in understanding of pathophysiology of cirrhosis and complications related with its treatment, results in enhanced management of this disease, quality of life and expectancy of affected people having cirrhosis. But currently, transplantation is solitary option for patients, but several pharmacological therapies that halt the progression to decompensated cirrhosis from compensated cirrhosis or can reverse cirrhosis to its normal state are currently being developed, there are few reports that says that they have reversed hepatic cirrhosis during prophylactic experimentation, but still curative studies are needed to further explored the process of reversal of cirrhosis to normal hepatic architecture. 58 Propolis in several fibrosis processes have been reported to hault and reversal of whole process of conversion of early stages of fibrosis to severe stages, but no any such reports are available currently that explains the role of propolis in cirrhosis. So, in cirrhosis role of propolis is still needs to be explored and its mechanism in pathophysiology of hepatic cirrhosis.

Propolis and Hepatocellular Carcinoma

The components of propolis possesses strong activity against several type of tumour cells and stops the process of angiogenesis and helps in cell cycle arrest in tumour cells. Compounds obtained from propolis such as CAPE 59 and artepillin C have been reported to possess anti-tumoral properties.60 This composition of propolis is involved in cell-cycle arrest, hault of matrix metalloproteinases, anti-angiogenesis consequence and inhibit transfer of cancer cells from their origin to other body parts. 61 Propolis has capability to halt DNA synthesis in cancer cells and the activity to cause aging of tumour cells (programmed cell death) and have the ability to place into action the white blood cells for engendering those molecules which are involved in the regulating the function of B, T, and natural killer cells.62 Several other compounds which are present in propolis including galangin, cardanol, nemorosone, caffeic acid, gallic acid, benzoic acid, and hespertin are involved to avoid the speedy division of cancer cells.63 The cytotoxic activity of natural killer cell was found to be increased with the use of propolis for three days against murine lymphoma.64 The occurrence of tumor suppresser proteins in CAPE results into apoptosis of the C6 glioma cells.65 Caffeic acid and their esters along with diterpenoids and phenolic compounds has the damaging aptitude towards cancer cells. Propolis anti-tumor effect is due to the polyphenolic constituents combined function present in it.66 Reduction in the construction of glutathione in tumour cells due to radiations, is subsequently fulfilled by propolis, as the synthesis of glutathione in haematopoietic tissues is maintained by propolis.67 Badria et al.,68 have reported cytotoxic activity of propolis against liver, breast, and colorectal cancer and have found that propolis is very effective in treatment of these cancer cells. Turan et al.,69 have observed the effect of propolis on colon, liver, breast, cervix, and prostate cancer cell line and found that compounds present in propolis acts on preventing the spread of cancer cells and inhibit their growth by encouraging apoptosis in these cancer cells. According to Sameni et al.,70 propolis extracted in ethanolic solution, was examined for its anti-cancer properties, they counted the aberrant crypt foci (ACF) and the pathological lesions in the distal colonic epithelial tissues, expression of beta-catenin, induced nitric oxide synthase and cyclooxygenase-2 proteins, as these proteins are majorly involved in the incidence and progression of tumour. Administering propolis significantly decreases the number of ACFs and pathological lesions when compared with cancer control groups. The propolis also reduced expression of above-mentioned proteins, responsible for causing and developing cancer.

Limitations

In this review, we have discussed only therapeutic role against several hepatic disorders from acute liver failure to hepatocellular carcinoma and have shown good therapeutic activity along with standard medications. Additionally, we focused on different pathological conditions of liver and their possible treatment with propolis. This review will help for proper liver medication in hepatic disorders and help to design potential drugs with propolis as only therapy or with adjuvants with less side effects and high specificity with its related hepatic abnormalities.

Conflicts of Interests

The authors have no financial interests or conflicts of interests.

Source of Funding

None.

References

1 

Y Irigoiti A Navarro D Yamul The use of propolis as a functional food ingredient: A reviewTrends Food Sci Technol20211297306

2 

C Esposito EU Garzarella B Bocchino M D'Avino G Caruso AR Buonomo A standardized polyphenol mixture extracted from poplar-type propolis for remission of symptoms of uncomplicated upper respiratory tract infection (URTI): A monocentric, randomized, double-blind, placebo-controlled clinical trialPhytomedicine20218015336810.1016/j.phymed.2020.153368

3 

M Pusceddu D Annoscia I Floris D Frizzera V Zanni A Angioni Honeybees use propolis as a natural pesticide against their major ectoparasiteProc Biol Sci19652219652021210110.1098/rspb.2021.2101

4 

MM Nichitoi AM Josceanu RD Isopescu Polyphenolics profile effects upon the antioxidant and antimicrobial activity of propolis extractsSci Rep2021111112

5 

LFA de M Oliveira LVA Teles da Silva TG Nascimento LM de Almeida RJ Nunes Calumby ÁM Nunes Antioxidant and antimicrobial activity of red propolis embedded mesoporous silica nanoparticlesDrug Dev Ind Pharm20204671199208

6 

N Rivera-Yañez CR Rivera-Yañez G Pozo-Molina Biomedical properties of propolis on diverse chronic diseases and its potential applications and health benefitsNutrients20202917810.3390/nu13010078

7 

S Alanazi N Alenzi F Alenazi Chemical characterization of Saudi propolis and its antiparasitic and anticancer propertiesSci Rep20218119

8 

FP Beserra LF Gushiken MF Hussni VP Ribeiro F Bonamin CJ Jackson Artepillin C as an outstanding phenolic compound of Brazilian green propolis for disease treatment: A review on pharmacological aspectsPhytother Res2021355227486

9 

GC Chan KW Cheung DM Sze The immunomodulatory and anticancer properties of propolisClin Rev Allergy Immunol201344326273

10 

Y Al Naggar G Yahya S Al-Kahtani Back to Ancient Remedy: Could Inhalation of Aerosolised-Honey and Propolis Tincture Protect Against the COVID-19 PandemicJournal of Apitherapy20218215

11 

Q Ding A R Sheikh X Gu J Li K Xia N Sun Chinese Propolis: Ultrasound-assisted enhanced ethanolic extraction, volatile components analysis, antioxidant and antibacterial activity comparisonFood Sci Nutr2021913133010.1002/fsn3.1997

12 

Y Fouad R Elwakil M Elsahhar The NAFLD-MAFLD debate: Eminence vs evidenceLiver Int20214122556010.1111/liv.14739

13 

T Kisseleva D Brenner Molecular and cellular mechanisms of liver fibrosis and its regressionNat Rev Gastroenterol Hepatol202118315166

14 

P Burra D Samuel V Sundaram C Duvoux H Petrowsky N Terrault Limitations of current liver donor allocation systems and the impact of newer indications for liver transplantationJ Hepatol202175Suppl 117890

15 

C Berk T Ammar B T Lee Acute liver failure due to manufactured alkaline water: a case series of “real water”-induced liver injuryOfficial journal of the American College of Gastroenterology| ACG202224104309

16 

M Bhadauria S K Nirala S Shukla Multiple treatment of propolis extract ameliorates carbon tetrachloride induced liver injury in ratsFood Chem Toxicol200846827031210.1016/j.fct.2008.04.025

17 

M Bhadauria S K Nirala S Shukla Propolis protects CYP 2E1 enzymatic activity and oxidative stress induced by carbon tetrachlorideMol Cell Biochem20073021-22152410.1007/s11010-007-9443-4

18 

AH Banskota Y Tezuka IK Adnyana Hepatoprotective and anti-Helicobacter pylori activities of constituents from Brazilian propolisPhytomedicine200181162310.1078/0944-7113-00004

19 

M Bhadauria Propolis prevents hepatorenal injury induced by chronic exposure to carbon tetrachlorideEvid Based Complement Alternat Med201223535810.1155/2012/235358

20 

YF Wen JQ Zhao SK Nirala Aluminum-Induced Toxicity and Its Response to Combined Treatment of HEDTA and Propolis in RatsPolish J Environ Stud2012215143743

21 

SK Nirala M Bhadauria Propolis reverses acetaminophen induced acute hepatorenal alterations: a biochemical and histopathological approachArch Pharmacal Res200831445161

22 

M Bhadauria SK Nirala Reversal of acetaminophen induced subchronic hepatorenal injury by propolis extract in ratsEnviron Toxicol Pharmacol2009271172510.1016/j.etap.2008.07.003

23 

M Bhadauria S Shukla R Mathur OP Agrawal S Shrivastava S Johri Hepatic endogenous defense potential of propolis after mercury intoxicationIntegr Zool20083431121

24 

SK Nirala M Bhadauria R Mathur Influence of α-tocopherol, propolis and piperine on therapeutic potential of tiferron against beryllium induced toxic manifestationsJ Appl Toxicol20082814454

25 

R Mesnage MN Antoniou D Tsoukalas GN Goulielmos A Tsatsakis Gut microbiome metagenomics to understand how xenobiotics impact human healthCurr Opin Toxicol20181151810.1016/j.cotox.2019.02.002

26 

Y Gao L Davies Forsman W Ren X Zheng Z Bao Y Hu Drug exposure of first-line anti-tuberculosis drugs in China: A prospective pharmacological cohort studyBr J Clin Pharmacol202187313475810.1111/bcp.14522

27 

DJ Pinato TU Marron PS Mishra-Kalyani Y Gong G Wei D Szafron Treatment-related toxicity and improved outcome from immunotherapy in hepatocellular cancer: Evidence from an FDA pooled analysis of landmark clinical trials with validation from routine practiceEur J Cancer20211571405210.1016/j.ejca.2021.08.020

28 

I Kaushik S Ramachandran S Prasad SK Srivastava Drug rechanneling: A novel paradigm for cancer treatmentSemin Cancer Biol2021682799010.1016/j.semcancer.2020.03.011

29 

L Bennardo F Bennardo A Giudice Local chemotherapy as an adjuvant treatment in unresectable squamous cell carcinoma: What do we know so far?Curr Oncol2021284231725

30 

K Singh M Bhori Y A Kasu Antioxidants as precision weapons in war against cancer chemotherapy induced toxicity-Exploring the armoury of obscuritySaudi Pharm J201826217790

31 

P Tatli Seven I Seven S Karakus SI Mutlu G Arkali YM Sahin Turkish propolis and its nano form can ameliorate the side effects of cisplatin, which is a widely used drug in the treatment of cancerPlants202099107510.3390/plants9091075

32 

T Benbow J Campbell Microemulsions as transdermal drug delivery systems for nonsteroidal anti-inflammatory drugs (NSAIDs): a literature reviewDrug Dev Ind Pharm20194512184955

33 

N Sahu G Mishra H K Chandra SK Nirala M Bhadauria Propolis modulates cellular biochemistry, antioxidants, cytokine profile, histological and ultra-morphological status against antituberculosis drugs induced hepatic injuryAsian Pacific J Trop Med201811116092010.4103/1995-7645.246337

34 

VW Wong GL Wong J Woo J Woo JM Abrigo C Ka-Man Chan Impact of the new definition of metabolic associated fatty liver disease on the epidemiology of the diseaseClin Gastroenterol Hepatol2021191021617110.1016/j.cgh.2020.10.046

35 

Z Younossi F Tacke M Arrese BC Sharma I Mostafa E Bugianesi Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitisHepatology2019696267282

36 

F Mansour-Ghanaei F Joukar SN Mobaraki S Mavaddati S Hassanipour M Sepehrimanesh Prevalence of non-alcoholic fatty liver disease in patients with diabetes mellitus, hyperlipidemia, obesity and polycystic ovary syndrome: A cross-sectional study in north of IranDiabetes Metab Syndr201913215916

37 

NN El-Agroudy A Kurzbach RN Rodionov J O'Sullivan 3 M Roden AL Birkenfeld Are Lifestyle Therapies Effective for NAFLD Treatment?Trends Endocrinol Metab20193010701910.1016/j.tem.2019.07.013

38 

K Kismet C Ozcan S Kuru OG Celemli P Celepli M Senes Does propolis have any effect on non-alcoholic fatty liver disease?Biomed Pharmacother2017908637110.1016/j.biopha.2017.04.062

39 

D Soleimani M Rezaie F Rajabzadeh JG Navashenaq M Abbaspour M Miryan Protective effects of propolis on hepatic steatosis and fibrosis among patients with nonalcoholic fatty liver disease (NAFLD) evaluated by real-time two-dimensional shear wave elastography: A randomized clinical trialPhytother Res202135316697910.1002/ptr.6937

40 

A Floreani P Restrepo-Jiménez MF Secchi SD Martin PSC Leung E Krawitt Etiopathogenesis of autoimmune hepatitisJ Autoimmun2018951334310.1016/j.jaut.2018.10.020

41 

E R Hassan Abd Al-Yamani M A Sayrafi M A Effect of Saudi Propolis on hepatitis male ratsJ Nutr Food Sci20177461910.4172/2155-9600.1000619

42 

F Mounieb L Ramadan E S Akool Propolis alleviates concanavalin A-induced hepatitis by modulating cytokine secretion and inhibition of reactive oxygen speciesNaunyn Schmiedebergs Arch Pharmacol20173901111051510.1007/s00210-017-1410-3

43 

AM El-Mahalaway AA Selim FA Mahboub The potential protective effect of propolis on experimentally induced hepatitis in adult male albino rats. Histological and immunohistochemical studyJ. Histol. Histopathol201521910.7243/2055-091X-2-14

44 

P Ginès L Castera F Lammert I Graupera M Serra-Burriel AM Allen Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseasesHepatology20227512192810.1002/hep.32163

45 

S Tao R Duan T Xu J Hong W Gu A Lin Salvianolic acid B inhibits the progression of liver fibrosis in rats via modulation of the Hedgehog signaling pathwayExp Ther Med202223211610.3892/etm.2021.11039

46 

S L Friedman F J Roll J Boyles D Bissell Hepatic lipocytes: the principal collagen-producing cells of normal rat liverProc Natl Acad Sci U S A198582248681510.1073/pnas.82.24.8681

47 

RC Shankaraiah E Callegari P Guerriero Metformin prevents liver tumourigenesis by attenuating fibrosis in a transgenic mouse model of hepatocellular carcinomaOncogene2019384570354510.1038/s41388-019-0942-z

48 

XK Zhao Y Cheng M Liang Cheng M Mu H Li Y Liu Focal Adhesion Kinase Regulates Fibroblast Migration via Integrin beta-1 and Plays a Central Role in FibrosisSci Rep201614112

49 

L Zhao L Pu J Wei Brazilian green propolis improves antioxidant function in patients with type 2 diabetes mellitusInt J Environ Res Public Health201613549810.3390/ijerph13050498

50 

CD Sadik AD Luster Lipid-cytokine-chemokine cascades orchestrate leukocyte recruitment in inflammationJ Leukoc Biol20129122071510.1189/jlb.0811402

51 

T Luangmonkong S Suriguga H A Mutsaers GMM Groothuis P Olinga M Boersema Targeting oxidative stress for the treatment of liver fibrosisRev Physiol Biochem Pharmacol20181757110210.1007/112_2018_10

52 

J Vallverdú MG De La Torre I Mannaerts S Verhulst A Smout M Coll Directed differentiation of human induced pluripotent stem cells to hepatic stellate cellsNat Protoc202116525426310.1038/s41596-021-00509-1

53 

C Zhang L Shi F S Wang Liver injury in COVID-19: management and challengesLancet Gastroenterol Hepatol2020554283010.1016/S2468-1253(20)30057-1

54 

B Das P C Maity A K Sil Vitamin C forestalls cigarette smoke induced NF-κB activation in alveolar epithelial cellsToxicology Letters201322017681

55 

L W Soromou L Jiang M Wei Protection of mice against lipopolysaccharide-induced endotoxic shock by pinocembrin is correlated with regulation of cytokine secretionJ Immunotoxicology20141115661

56 

MM Said SS Azab NM Saeed E El-Demerdash Antifibrotic mechanism of pinocembrin: impact on oxidative stress, inflammation and TGF-β/Smad inhibition in ratsAnn Hepatol20181723071710.5604/01.3001.0010.8661

57 

BM Izzularab M Megeed M Yehia Propolis nanoparticles modulate the inflammatory and apoptotic pathways in carbon tetrachloride-induced liver fibrosis and nephropathy in ratsEnviron Toxicol2021361556610.1002/tox.23010

58 

H Yoshiji S Nagoshi T Akahane Evidence-based clinical practice guidelines for Liver Cirrhosis 2020J Gastroenterol2021567593619

59 

F Tacke R Weiskirchen An update on the recent advances in antifibrotic therapyExpert Rev Gastroenterol Hepatol20181211114352

60 

S Castaldo F Capasso Propolis, an old remedy used in modern medicineFitoterapia200273Suppl 11610.1016/s0367-326x(02)00185-5

61 

J M Sforcin Propolis and the immune system: a reviewJ Ethnopharmacol2007113111410.1016/j.jep.2007.05.012

62 

K Salomao E M De Souza A Henriques-Pons Brazilian Green Propolis: Effects In Vitro and In Vivo on Trypanosoma cruziEvid Based Complement Alternat Med2011118591810.1093/ecam/nep014

63 

VD Wagh Propolis: a wonder bees product and its pharmacological potentialsAdv Pharmacol Sci2013930824910.1155/2013/308249

64 

JM Sforcin Biological properties and therapeutic applications of propolisPhytother Res201630689490510.1002/ptr.5605

65 

H Fokt A Pereira A M Ferreira How do bees prevent hive infections? The antimicrobial properties of propolisCurr Res, Technol Educ Top Appl Microbiol Microbial Biotechnol2010148193

66 

MA Watanabe MK Amarante BJ Conti Cytotoxic constituents of propolis inducing anticancer effects: a reviewJ Pharm Pharmacol2011631113788610.1111/j.2042-7158.2011.01331.x

67 

M Lotfy Biological activity of bee propolis in health and diseaseAsian Pac J Cancer Prev2006712231

68 

F Badria H Fathy A Fatehe Evaluate the cytotoxic activity of honey, propolis, and bee venom from different localities in Egypt against liver, breast, and colorectal cancerJ Apither201721110.5455/ja.20170203075953

69 

I Turan S Demir S Misir Cytotoxic effect of Turkish propolis on liver, colon, breast, cervix and prostate cancer cell linesTrop J Pharm Res201514577782

70 

HR Sameni S Yosefi M Alipour Co-administration of 5FU and propolis on AOM/DSS induced colorectal cancer in BALB-c miceLife Sci202127611939010.1016/j.lfs.2021.119390



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.